Recent

% | $
Quotes you view appear here for quick access.

Pacific Biosciences of California, Inc. Message Board

  • codyoot codyoot Jun 7, 2013 4:57 PM Flag

    Oxford Nanopore, Illumina to Cut Ties

    NEW YORK (GenomeWeb News) – Oxford Nanopore Technologies said today in its annual report that a commercialization agreement it had with Illumina will terminate on June 30, 2016.

    Ross Muken, an analyst from the ISI Group, said that he does not see the fracturing of the Illumina and Oxford's relationship as a major development for Illumina's stock "as most investors had heavily discounted the success rate of Oxford over the past nine months.

    "We continue to view Oxford as an intriguing company with a compelling technology. However, the technical complications of nanopore-based sequencing make the commercial feasibility of the products highly uncertain," he added.

 
PACB
5.59-0.1700(-2.95%)Apr 27 4:00 PMEDT